FDA Inspection
Department Of Defense - Air ForceDepartment Of Defense - Air Force – FDA Inspection, Mar 7, 2019
Record Details
This FDA Inspection record concerns Department Of Defense - Air Force, with an inspection on March 7, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a3ce80c1-53ea-4725-b763-ba59bde65892
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1081722
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department Of Defense - Air Force
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 10, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 2, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 25, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 14, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department Of Defense - Air Force
- FDA Inspection 1246901 - 2024-08-14
- FDA Inspection 1019124 - 2017-07-10
- FDA Inspection 921583 - 2015-04-02
- FDA Inspection 829267 - 2013-04-25
- FDA Inspection 734698 - 2011-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.